86% of patients on 400+ mg of INCA033989 had a complete or partial hematologic response. 89% of patients showed a reduction in mutCALR VAF, with 21% achieving >50% drop in just three cycles. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results